Status:
UNKNOWN
Malaria Genetic Surveillance
Lead Sponsor:
University of Oxford
Conditions:
Plasmodium Falciparum and Plasmodium Vivax
Eligibility:
All Genders
Brief Summary
This study is to determine the prevalence and geographical distribution of antimalarial drug resistance-linked genetic mutations in clinical P. falciparum and/or P.Vivax infection in the Greater Mekon...
Detailed Description
This is a prospective observational study of patients with clinical Plasmodium falciparum and/or Plasmodium Viviax infection using parasite DNA from point-of-care fingerprick dried blood spot samples ...
Eligibility Criteria
Inclusion
- Male or female of any age
- P. falciparum and/or P.Vivax malaria as confirmed by positive rapid diagnostic test or asexual forms of P. falciparum on blood smear microscopy (may be mixed with non-falciparum Plasmodium species)
- Written informed consent by patient, parent/guardian, or legally authorised representative to participate in the study
Exclusion
- None
Key Trial Info
Start Date :
October 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 31 2023
Estimated Enrollment :
30000 Patients enrolled
Trial Details
Trial ID
NCT03384498
Start Date
October 1 2016
End Date
January 31 2023
Last Update
March 23 2022
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
National Centre for Malaria Control, Parasitology and Entomology (CNM)
Phnom Penh, Cambodia
2
Center of Malariology, Parasitology and Entomology
Vientiane, Laos
3
Institute of Malariology, Parasitology, and Entomology Quy Nhon
Qui Nhon, Vietnam